IRCT2014120620218N1
已完成
2 期
Evaluation of the effect of Aspirin in pregnancy outcomes in patients with abnormal down syndrome biochemical tests and with normal karyotype
Vice chancellor for research, Kerman University of Medical Sciences0 个研究点目标入组 85 人待定
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- pregnancy.
- 发起方
- Vice chancellor for research, Kerman University of Medical Sciences
- 入组人数
- 85
- 状态
- 已完成
- 最后更新
- 8年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •pregnant women with abnormal biochemical tests in second trimester which have normal karyotype; consent of the patients.
- •Exclusion criteria: history of sensitivity to aspirin; asthma; Peptic ulcer; renal failure; gout; multifetal pregnancy; gestational diabetes; hemorrhage in first half of pregnancy; maternal disorders; congenital anomalies.
排除标准
- 未提供
结局指标
主要结局
未指定
相似试验
已完成
3 期
Aspirin administration from early pregnancy versus initiation after 11 week’s gestations, for prevention of pre-eclampsia in high-risk pregnant women.High Risk Pregnancy for preeclampsia.Supervision of high-risk pregnancyIRCT20221126056611N1Tehran University of Medical Sciences200
已完成
不适用
Preterm Birth Prevention Study follow-up in looking at Neurodevelopmental delayCTRI/2021/06/034432Thrasher Research Fund4,820
已完成
3 期
ASPIRIN- Preterm Birth Prevention StudyCTRI/2016/05/006970Eunice Kennedy Shriver National Institute of Child Health and Human Development4,829
已完成
不适用
Aspirin for prevention of adverse pregnancy outcome in women with elevated alfa-feto proteiElevated level of alfa fetoprotein in second trimester screening.IRCT201203018954N1Tehran University of Medical Sciences109
已完成
不适用
The Effects of Aspirin in Gestation and ReproductionBirthSpontaneous AbortionNCT00467363Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,228